AIM
Acropolis Investment Management Portfolio holdings
AUM
$1.82B
This Quarter Return
+13.27%
1 Year Return
+10.81%
3 Year Return
+36.86%
5 Year Return
+58.03%
10 Year Return
+101.2%
AUM
$909M
AUM Growth
+$909M
(+13%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
1.29%
Top 10 Holdings %
Top 10 Hldgs %
72.68%
Holding
216
New
15
Increased
80
Reduced
65
Closed
2
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
$7.41M |
| 2 |
Vanguard Total Bond Market
BND
|
$4.81M |
| 3 |
iShares MSCI Intl Momentum Factor ETF
IMTM
|
$3.42M |
| 4 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$2.72M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$2.49M |
Top Sells
| 1 |
Microsoft
MSFT
|
$5.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
$3.38M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$2.99M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
$2.5M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
$1.03M |
Sector Composition
| 1 | Technology | 2.54% |
| 2 | Industrials | 1.72% |
| 3 | Healthcare | 1.55% |
| 4 | Consumer Discretionary | 1.43% |
| 5 | Financials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Utilities Select Sector SPDR Fund
XLU
$20.9B
| $118K | 0.01% |
1,880
| – | – |
|
202
Medtronic
MDT
$119B
| $115K | 0.01% |
984
+7
| +0.7% | +$818 |
|
203
Invesco NASDAQ Internet ETF
PNQI
$794M
| $114K | 0.01% |
500
| – | – |
|
204
Schwab US Broad Market ETF
SCHB
$36.2B
| $113K | 0.01% |
+1,244
| New | +$113K |
|
205
HP
HPQ
$26.7B
| $111K | 0.01% |
+4,500
| New | +$111K |
|
206
GraniteShares Gold Shares
BAR
$1.14B
| $110K | 0.01% |
5,830
| – | – |
|
207
CSX Corp
CSX
$60.6B
| $107K | 0.01% |
+1,181
| New | +$107K |
|
208
Schwab Emerging Markets Equity ETF
SCHE
$10.7B
| $107K | 0.01% |
+3,481
| New | +$107K |
|
|
ATHX
209
DELISTED
Athersys, Inc. Common Stock
ATHX
| $105K | 0.01% |
60,000
+4,000
| +7% | +$7K |
|
210
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $104K | 0.01% |
1,255
| – | – |
|
211
Innovative Industrial Properties
IIPR
$1.59B
| $102K | 0.01% |
+555
| New | +$102K |
|
212
D.R. Horton
DHI
$50.5B
| $101K | 0.01% |
+1,466
| New | +$101K |
|
213
Moderna
MRNA
$9.37B
| – | – |
-6,060
| Closed | -$429K |
|
214
Oracle
ORCL
$635B
| – | – |
-1,732
| Closed | -$103K |
|